Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. - Wikidata - wikimedia - TriplyDB

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

http://www.wikidata.org/entity/Q33365628

about

Gallbladder Cancer in the 21st Century.Advances in systemic therapy for advanced pancreatobiliary malignancies Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer.Hepatic intra-arterial chemotherapy in patients with advanced primary liver tumours.A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.Long term responders to palliative chemotherapy for advanced biliary tract cancer.Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function Chemotherapy and targeted therapy for gall bladder cancer.Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.Multi-disciplinary treatment for cholangiocellular carcinoma.Update on the management of cholangiocarcinoma.A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.Systemic Therapy of Cholangiocarcinoma.Guidelines for chemotherapy of biliary tract and ampullary carcinomas Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.Routine histopathology for carcinoma in cholecystectomy specimens not evidence based: a systematic review.Gemcitabine and s-1 combination chemotherapy in patients with advanced biliary tract cancer: a retrospective study.Current management of gallbladder carcinoma.NCCN clinical practice guidelines in oncology: hepatobiliary cancers Tumors of ampulla of Vater: A case series and review of chemotherapy options Gallbladder cancer: expert consensus statement.SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.Is an aggressive surgical approach worthwhile in biliary cancer?Chemotherapy for advanced cholangiocarcinoma: what is standard treatment?Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial.Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Emerging drugs for biliary cancer.Thromboembolism in gastrointestinal cancers.

P2860

Q26784174-E429FCE5-21EC-4BB5-9629-3BE4CE455FC9 Q26822703-4DC3FE06-E45F-40E8-A5C7-A93F0C5AE209 Q30234532-2009DDC0-B823-46D3-A679-78F5C347053D Q30300756-0F0BB908-9624-4EDE-8A88-817DAAA12B0F Q30318857-13E0AE7B-E0BD-498B-91CD-300B9511922D Q33371325-3DCB3B11-9F1A-4D87-96EB-CC1FAFF040C6 Q33372640-9F8B0E2C-EA3F-4B1B-81BD-C7CDA99E7514 Q33381056-F6E5318D-0042-4C5C-9049-FF031EEECAA2 Q33391729-80C810EE-164C-46BC-BD52-2753871FFCA3 Q33394065-AFDCE5DE-2B8A-402C-9AC7-35DD12EFD0C3 Q33398969-7545FAFE-CC8A-42A3-B81D-D0F569CEBE8B Q33399656-CC0B23F5-9E76-4A9D-AAD1-4E766362C85E Q33402129-559014CD-FD2E-4252-9258-53218CBA8E9B Q33404756-6C86A482-C72C-4A9C-91B7-96F19426651B Q33404952-66F9CACE-F91A-4A87-BF30-FF0764D47C6B Q33419175-729A8FAA-9AB7-4AD1-94C2-416946F9739D Q33420043-D395524D-15EA-4372-AD49-48D30B1EE246 Q33593193-DAFEF904-6A8C-4170-AC55-C40C962BC67C Q33593207-FE49AE42-CF3C-4A71-80FC-1AB05A3946AB Q33977171-27FFAB0E-0836-4F84-8561-46AE74FA64CD Q34048813-0653C2EA-73F5-49B1-B41F-F3DF4A846DC3 Q34099099-5AE450C9-547C-4736-88EA-8A5D52F01E48 Q34153255-6879EEC1-FEFC-4DEE-9A69-5B322AB35C84 Q34307050-DDB44C6F-E334-48C2-8EC4-849A9936135E Q34551877-E1EEBD73-499D-4838-B6E5-0A1DACC6BC9F Q34588361-F8B121B2-DAF9-4C4B-9594-C13823909DB3 Q34623728-7723E4FF-1DBB-48FF-AC5D-B75275551228 Q34858544-95BBACAB-3116-456A-97C2-E26F18DE019D Q34999918-C1122BD8-25A6-41AF-8A98-776BEA6C6A4A Q35583920-299A3254-8348-4A5C-AED7-1889DD37388D Q35703937-D11072DF-1681-4FBD-9846-53AF13CA0495 Q35854505-F03EF832-E116-4FB3-AEA1-2582EF9A2C09 Q35924976-F950705A-578E-41D9-AF58-23A61F3EA735 Q35947011-0ED2774E-5A1E-4F09-8D51-657A2B52326C Q36397621-D62DBE80-C091-4111-BAF9-978C68ED8033 Q36572534-5582C621-DE8B-479D-9A7C-68D3758C99EE Q36614800-1E5F2D70-792F-4EE1-BFBE-FFFA354AB172 Q36962011-95722A48-E84A-4990-BEE2-579298D73EA3 Q36989921-24E8408F-1134-4C62-9DC9-D5A0BF96E0C3 Q37076622-9A9FA158-99F5-485E-B0D5-48E1E6212418

P2860

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

http://www.wikidata.org/entity/Q33365628

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Combining gemcitabine and cape ...... iary cancer: a phase II trial.

@ast

Combining gemcitabine and cape ...... iary cancer: a phase II trial.

@en

type

label

Combining gemcitabine and cape ...... iary cancer: a phase II trial.

@ast

Combining gemcitabine and cape ...... iary cancer: a phase II trial.

@en

prefLabel

Combining gemcitabine and cape ...... iary cancer: a phase II trial.

@ast

Combining gemcitabine and cape ...... iary cancer: a phase II trial.

@en

P1433

Q33365628-9FBA88A2-D828-49D5-90EE-18B49BAF5898

P1476

Q33365628-1BB25E27-4815-49AC-96A9-703CD596D13D

P2093

Q33365628-664B4DD6-B44A-495B-9D39-292464789C6B

Q33365628-6ED1C083-8444-4D49-B41A-40DFB889F1F5

Q33365628-7A134ED7-A3C6-4267-823F-FD46EEABA960

Q33365628-7AA678DC-F92B-4400-B896-F303969EC865

Q33365628-88458914-C11B-4F09-B979-83071A994A0D

Q33365628-D07C41DD-53DB-4E0F-8FAA-47CC360F83A7

Q33365628-D5505B11-2DE2-4A6D-8296-C9F1DB5B4FFC

Q33365628-D716D901-1448-4F34-AFBD-F6E40FE80B08

Q33365628-E3E3E74B-8039-488D-B7C1-F5385C6B699D

P304

Q33365628-91696121-060E-4DBD-BD5D-EF01674D354C

P31

Q33365628-CF3D8595-F3FC-45DB-8680-561815E78B7A

P356

Q33365628-894EA59B-E9B2-488B-9EE0-46E2BE891E35

P407

Q33365628-7442BB92-4B72-4640-AB54-0E8B86B2B4BF

P433

Q33365628-1653CA9A-D455-4CEF-9E59-72179BAC5FD3

P478

Q33365628-1967ACCC-EC3C-4948-81E7-7EADC2BFE6F9

P50

Q33365628-C6C6AFD6-C385-4E1B-8B0E-7C9287348BCE

P577

Q33365628-EB3B42D3-950B-41BC-89E9-803AEDB0F86D

P5875

Q33365628-EDD60DDA-3F3D-4860-B853-64C01D1ABA68

P698

Q33365628-A6557F83-EB1C-4868-81AC-2D908D400CC4

P921

Q33365628-C85A0A2E-62EB-4EEA-A8F7-E80CD47C0B90

P356

JCO.2005.51.008

P1433

Journal of Clinical Oncology

P1476

Combining gemcitabine and cape ...... iary cancer: a phase II trial.

@en

P2093

Amit Oza

http://www.w3.org/2001/XMLSchema#string

Eric Chen

http://www.w3.org/2001/XMLSchema#string

Gregory R Pond

http://www.w3.org/2001/XMLSchema#string

Jennifer J Knox

http://www.w3.org/2001/XMLSchema#string

Jessica Zhang

http://www.w3.org/2001/XMLSchema#string

Lillian L Siu

http://www.w3.org/2001/XMLSchema#string

Mahsan Nematollahi

http://www.w3.org/2001/XMLSchema#string

Malcolm J Moore

http://www.w3.org/2001/XMLSchema#string

Ron Feld

http://www.w3.org/2001/XMLSchema#string

P304

2332-2338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.51.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7936344

http://www.w3.org/2001/XMLSchema#string

P698

15800324

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial